methyl 3-(5-bromofuran-2-yl)acrylate | 50527-71-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl 3-(5-bromofuran-2-yl)acrylate
• 英文别名: methyl 3-(5-bromofuran-2-yl)prop-2-enoate
• CAS: 50527-71-4
• 化学式: C₈H₇BrO₃
• 分子量: 231.046
• InChiKey: HHPXRRQKAZDWDG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  39.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 3-(5-bromofuran-2-yl)acrylate 在 bis-triphenylphosphine-palladium(II) chloride 、 sodium tetrahydroborate 、 copper(l) iodide 、 氢气 、 nickel(II) acetate tetrahydrate 、 二异丁基氢化铝 、 乙二胺 、 三乙胺 、 三苯基膦 、 sodium hydroxide 作用下， 以 四氢呋喃 、 乙醇 、 正己烷 、 二氯甲烷 、 水 为溶剂， 反应 4.0h， 生成
  参考文献：
  名称：

  Synthesis and Biological Evaluation of Neopeltolide and Analogs

  摘要：

  The synthesis of neopeltolide analogues that contain variations in the oxazole-containing side chain and in the macrolide core are reported along with the GI(50) values for these compounds against MCF-7, HCT-116, and p53 knockout HCT-116 cell lines. Although biological activity is sensitive to changes in the macrocycle and the side chain, several analogues displayed GI(50) values of <25 nM. Neopeltolide and several of the more potent analogues were significantly less potent against p53 knockout cells, suggesting that p53 plays an auxiliary role in the activity of these compounds.

  DOI：

  10.1021/jo2023685
• 作为产物：
  描述：

  5-溴-2-呋喃甲醛 、 甲氧羰基亚甲基三苯基正膦 以 甲苯 为溶剂， 反应 1.0h， 以77%的产率得到methyl 3-(5-bromofuran-2-yl)acrylate
  参考文献：
  名称：

  WO2006/53791

  摘要：

  公开号：

文献信息

• Novel biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
  申请人：Boiteau Jean-Guy

  公开号：US20080027077A1

  公开（公告）日：2008-01-31

  Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the fields of cardiovascular diseases, of immune diseases and/of diseases related to the metabolism of lipids), or, alternatively, in cosmetic compositions.

  具有一般式(I)的新型双芳香族化合物及其所含的化妆品/药物组合物在人类或兽医学中（在皮肤科以及心血管疾病、免疫疾病和/或与脂质代谢有关的疾病领域）或者在化妆品组合物中是有用的。
• Biaromatic compounds that modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
  申请人：Galderma Research & Development

  公开号：US08129416B2

  公开（公告）日：2012-03-06

  Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the fields of cardiovascular diseases, of immune diseases and/of diseases related to the metabolism of lipids), or, alternatively, in cosmetic compositions.

  具有通式（I）的新型双芳香化合物和由此组成的化妆品/药物组合物在人类或兽医学中（在皮肤病学以及心血管疾病、免疫疾病和/或与脂质代谢有关的疾病领域中）非常有用，或者在化妆品中使用。
• NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARy TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
  申请人：BOITEAU Jean-Guy

  公开号：US20120121527A1

  公开（公告）日：2012-05-17

  Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the fields of cardiovascular diseases, of immune diseases and/of diseases related to the metabolism of lipids), or, alternatively, in cosmetic compositions.

  具有一般式(I)的新型双芳香族化合物及其所包含的化妆品/药物组合物在人类或兽医学领域（在皮肤科以及心血管疾病、免疫疾病和/或与脂质代谢有关的疾病领域）中非常有用，或者在化妆品组合物中使用。
• NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARY TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
  申请人：Galderma Research & Development

  公开号：US20130303549A1

  公开（公告）日：2013-11-14

  Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the fields of cardiovascular diseases, of immune diseases and/of diseases related to the metabolism of lipids), or, alternatively, in cosmetic compositions.

  具有通式(I)的新型双芳香化合物及其所包含的化妆品/药品组合物在人类或兽医医学上具有用途（在皮肤科，以及心血管疾病、免疫疾病和/或与脂质代谢相关的疾病领域），或者在化妆品组合物中也可以使用。
• Biaromatic compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
  申请人：Boiteau Jean-Guy

  公开号：US08513297B2

  公开（公告）日：2013-08-20

  Novel biaromatic compounds having the general formula (I): and cosmetic/pharmaceutical compositions comprised thereof are useful in human or veterinary medicine (in dermatology and also in the fields of cardiovascular diseases, of immune diseases and/of diseases related to the metabolism of lipids), or, alternatively, in cosmetic compositions.

  具有通式（I）的新型双芳香化合物以及由此组成的化妆品/医药组合物在人类或兽医学（在皮肤科以及心血管疾病、免疫疾病和/或与脂质代谢相关的疾病领域）中有用，或者在化妆品组合物中有用。